Banner image placeholder
Banner image
Site avatar

A. Alex Levine, PhD, MPH

Disability and Aging Researcher

How might US health plans cover efgartigimod for generalized myasthenia gravis? Lessons from the SPEC Database


Journal article


Adele Levine, James Chambers
Center for the Evaluation of Value and Risk in Health. November, vol. 4, 2021

Cite

Cite

APA   Click to copy
Levine, A., & Chambers, J. (2021). How might US health plans cover efgartigimod for generalized myasthenia gravis? Lessons from the SPEC Database. Center for the Evaluation of Value and Risk in Health. November, 4.


Chicago/Turabian   Click to copy
Levine, Adele, and James Chambers. “How Might US Health Plans Cover Efgartigimod for Generalized Myasthenia Gravis? Lessons from the SPEC Database.” Center for the Evaluation of Value and Risk in Health. November 4 (2021).


MLA   Click to copy
Levine, Adele, and James Chambers. “How Might US Health Plans Cover Efgartigimod for Generalized Myasthenia Gravis? Lessons from the SPEC Database.” Center for the Evaluation of Value and Risk in Health. November, vol. 4, 2021.


BibTeX   Click to copy

@article{levine2021a,
  title = {How might US health plans cover efgartigimod for generalized myasthenia gravis? Lessons from the SPEC Database},
  year = {2021},
  journal = {Center for the Evaluation of Value and Risk in Health. November},
  volume = {4},
  author = {Levine, Adele and Chambers, James}
}


Share

Translate to